http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220082862-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
filingDate 2020-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f17ea3bc067a5789508b906e0daacf4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1914b8574dc362647dfc4e388f97eed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39a4538c8b96600ba3620f83506d1523
publicationDate 2022-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20220082862-A
titleOfInvention Combination therapy to treat hematologic malignancies
abstract To a subject in need thereof, administer an effective amount of ( 3R )-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyri) to a subject in need thereof. dazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one or a pharmaceutically acceptable salt thereof and an effective amount of Venetoclax or a pharmaceutical thereof Disclosed is a method of administering cancer, comprising administering an acceptable salt.
priorityDate 2019-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85557
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID596
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID31722
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396282
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22094277
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID738409
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID57261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411675801
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID474868
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14312
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID570772
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24224
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281020
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID53585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49846579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422454219
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID327372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID676
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID446381
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30445
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID67382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413496939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419564680
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6046
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114642
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10095
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID505358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12043
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403416
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID570531

Total number of triples: 60.